Brief: Amarantus Subsidiary Elto Pharma Receives Notice Of Allowance Covering Use Of Eltoprazine Combined With CBD To Treat Parkinson's Disease04/12/2019 12:40
Last trade - 00:00Last trade - 00:00Last trade - 00:00